Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:BCR

C.R. Bard (BCR) Stock Price, News & Analysis

C.R. Bard logo

About C.R. Bard Stock (NYSE:BCR)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$331.24
$331.24
50-Day Range
N/A
52-Week Range
$222.42
$337.73
Volume
N/A
Average Volume
679,456 shs
Market Capitalization
N/A
P/E Ratio
21.91
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.

Remove Ads
Receive BCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for C.R. Bard and its competitors with MarketBeat's FREE daily newsletter.

BCR Stock News Headlines

D&D: Every Bard College, Ranked
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
Bard College welcomes refugee students
DnD 5e: Every Bard College, Ranked
See More Headlines

BCR Stock Analysis - Frequently Asked Questions

C.R. Bard Inc (NYSE:BCR) issued its quarterly earnings results on Wednesday, October, 25th. The medical instruments supplier reported $3.02 EPS for the quarter, topping analysts' consensus estimates of $2.96 by $0.06. C.R. Bard's quarterly revenue was up 5.1% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that C.R. Bard investors own include Becton, Dickinson and Company (BDX), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), AbbVie (ABBV), Baxter International (BAX), Boston Scientific (BSX) and Johnson & Johnson (jnj).

Company Calendar

Last Earnings
10/25/2017
Today
4/02/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:BCR
CIK
9892
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
21.91
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NYSE:BCR) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners